ArticleCancer gene therapy2020
Targeting LRIG2 overcomes resistance to EGFR inhibitor in glioblastoma by modulating GAS6/AXL/SRC signaling.
Minhai Dong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
13 papers cite it
this papercites it
ArticleCancer gene therapy2020
Minhai Dong et al.PubMed ↗Publisher ↗
No numbers read from the abstract.